Inside Health Policy: LTC Pharmacies To HHS: Remove Us From Provider Relief Cap
By Dorothy Mills-Gregg
Inside Health Policy
Long-term care pharmacies are asking HHS to separate them from retail pharmacies when calculating Phase 4 provider relief distributions, calling the 10% cap on annual patient care revenue arbitrary and unfair when long-term care pharmacies’ average patient care revenues are 30% to 35% of their total revenues.
Long-term care pharmacies are also concerned they’re being left out of the rural provider relief distribution because HHS won’t count Medicare Part D and other bundled payments as revenue indirect payments that suppliers received from nursing homes.
HHS didn’t formally recognize long-term care pharmacies as eligible for provider relief until April 2021, five months after the Phase 3 distribution closed. The Senior Care Pharmacy Coalition members who applied before the announcement received mixed results — some were rejected for COVID-19 relief while others who received it sometimes had it taken away.
Now long-term and retail pharmacies qualify for provider relief, but HHS will only reimburse lost patient care revenues and expenses, like staffing and medical supplies. Pharmacies cannot be reimbursed for lost revenue attributable to selling fewer drugs or product.
“Like it or not, the limitation on ‘okay, we don’t pay for stuff’ — I get it. But why then cap it after you’ve said that. That’s what I don’t get,” SCPC President and CEO Alan Rosenbloom said.
The agency in charge of distributing provider relief, the Health Resources and Services Administration, said it used industry estimates of revenue and operating expenses from patient care to set the cap at 10% on pharmacies’ and durable medical equipment suppliers’ claimed annual gross revenue.
But the SCPC says long-term care pharmacies’ average patient care revenues are 30% to 35% of their total revenue. Advocates say it would be easy for HRSA to exclude long-term care pharmacies from the cap.
“It doesn’t increase the administrative burden, it doesn’t require re-doing the methodology, and it is a fair solution,” Rosenbloom said. “It’s particularly disappointing to me because there’s a lot of discussion about trying to make the distributions from the provider relief fund more equitable than they have been in the past and fairer to providers that may have not quite gotten a fair shake last year, and somehow that hasn’t happened for long-term care pharmacies.”
SCPC is also concerned that HRSA will not count indirect payments as revenue when calculating the American Rescue Plan rural distribution. This limits how much long-term care pharmacies can receive in rural provider relief as part of their revenue comes from Medicare Part A and Medicare Advantage bundled payments paid to nursing facilities for redistribution. HRSA also won’t count Medicare Part D as revenue.
“So how can you say pharmacies are eligible for relief, and pharmacies provide patient care services, and those patient care services are recognized in terms of payment by what you get for Part D dispensing fees, but we’re going to consider them?” Rosenbloom said.
If the administration’s commitment is to equity, then HHS should be able to fix these two issues by the Phase 4 distribution application deadline of Oct. 26, he added.
To view the original article click here.
Recent Posts
-
SCPC Applauds Bipartisan Group of Lawmakers Calling for Critical Changes to Medicare Drug Price Negotiations
The Senior Care Pharmacy Coalition (SCPC), the leading national voice for the long-term care (LTC) pharmacy community, released the following statement commending Chairman Buddy Carter, Rep. Jake Auchincloss and other Members of Congress for urging HHS and CMS to examine the looming impact of Medicare drug price negotiations on America’s pharmacies.
-
SCPC Releases Statement in Support of Government Accountability Office (GAO) Report on the Inflation Reduction Act
SCPC has repeatedly warned about the impact of the Inflation Reduction Act’s (IRA) mandatory Medicare drug price negotiations on LTC pharmacies and the millions of vulnerable seniors they serve. We are glad the Government Accountability Office (GAO) is examining how these policies are affecting pharmacies, particularly LTC pharmacies, which already operate under a broken reimbursement model that often requires them to dispense many of the most commonly used medications at a loss.
-
SCPC Applauds President Trump’s Executive Order Calling on HHS and Congress to Improve the IRA, Rein In PBMs and Lower Drug Costs
The Senior Care Pharmacy Coalition (SCPC), the leading national voice for the long-term care (LTC) pharmacy community, released the following statement applauding President Trump’s recent Executive Order aimed at improving the Inflation Reduction Act (IRA), lowering drug prices and addressing the harmful actions of PBMs. “For far too long, pharmacy benefit managers (PBMs) have taken […]
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.